TABLE 2.
Correlation of circ_0015278 expression with PTC patients’ characteristics
| Items | Circ_0015278 expression | ||||
|---|---|---|---|---|---|
| Q1 (1%−25%) (n = 52) | Q2 (26%−50%) (n = 51) | Q3 (51%−75%) (n = 52) | Q4 (76%−100%) (n = 51) | p Value | |
| Age, no. (%) | |||||
| <45 years | 23 (44.2) | 23 (45.1) | 26 (50.0) | 34 (66.7) | 0.021 |
| ≥45 years | 29 (55.8) | 28 (54.9) | 26 (50.0) | 17 (33.3) | |
| Gender, no. (%) | |||||
| Male | 12 (23.1) | 17 (33.3) | 11 (21.2) | 10 (19.6) | 0.404 |
| Female | 40 (76.9) | 34 (66.7) | 41 (78.8) | 41 (80.4) | |
| Tumor size, no. (%) | |||||
| ≤4 cm | 31 (59.6) | 30 (58.8) | 32 (61.5) | 38 (74.5) | 0.117 |
| >4 cm | 21 (40.4) | 21 (41.2) | 20 (38.5) | 13 (25.5) | |
| Extrathyroidal invasion, no. (%) | |||||
| Absent | 25 (48.1) | 29 (56.9) | 34 (65.4) | 34 (66.7) | 0.036 |
| Present | 27 (51.9) | 22 (43.1) | 18 (34.6) | 17 (33.3) | |
| pT stage, no. (%) | |||||
| pT1 | 9 (17.4) | 2 (3.9) | 7 (13.5) | 11 (21.6) | 0.005 |
| pT2 | 5 (9.6) | 20 (39.2) | 18 (34.6) | 19 (37.2) | |
| pT3 | 19 (36.5) | 13 (25.5) | 12 (23.1) | 11 (21.6) | |
| pT4 | 19 (36.5) | 16 (31.4) | 15 (28.8) | 10 (19.6) | |
| pN stage, no. (%) | |||||
| pN0 | 12 (23.1) | 13 (25.5) | 19 (36.5) | 25 (49.0) | 0.002 |
| pN1 | 40 (76.9) | 38 (74.5) | 33 (63.5) | 26 (51.0) | |
| pTNM stage, no. (%) | |||||
| I | 25 (48.1) | 23 (45.2) | 27 (51.9) | 36 (70.6) | 0.001 |
| II | 1 (1.9) | 4 (7.8) | 5 (9.6) | 6 (11.8) | |
| III | 15 (28.8) | 15 (29.4) | 8 (15.4) | 9 (17.6) | |
| IV | 11 (21.2) | 9 (17.6) | 12 (23.1) | 0 (0.0) | |
Abbreviations: pN, pathological node; pT, pathological tumor; PTC, papillary thyroid carcinoma; pTNM, pathological tumor‐node‐metastasis; Q1, quantile 1; Q2, quantile 2; Q3, quantile 3; Q4, quantile 4.